0001493152-18-015463.txt : 20181108 0001493152-18-015463.hdr.sgml : 20181108 20181108153448 ACCESSION NUMBER: 0001493152-18-015463 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181108 DATE AS OF CHANGE: 20181108 EFFECTIVENESS DATE: 20181108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vitality Biopharma, Inc. CENTRAL INDEX KEY: 0001438943 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 753268988 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-325386 FILM NUMBER: 181169485 BUSINESS ADDRESS: STREET 1: 1901 AVENUE OF THE STARS, 2ND FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90067 BUSINESS PHONE: 530-231-7800 MAIL ADDRESS: STREET 1: 1901 AVENUE OF THE STARS, 2ND FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90067 FORMER COMPANY: FORMER CONFORMED NAME: Stevia First Corp. DATE OF NAME CHANGE: 20111020 FORMER COMPANY: FORMER CONFORMED NAME: Legend Mining Inc. DATE OF NAME CHANGE: 20080630 D 1 primary_doc.xml X0708 D LIVE 0001438943 Vitality Biopharma, Inc. 1901 AVENUE OF THE STARS, 2ND FLOOR LOS ANGELES CA CALIFORNIA 90067 530-231-7800 NEVADA Legend Mining, Inc. Stevia First Corp. Legend Mining Inc. Corporation true Robert Brooke 1901 Avenue of the Stars, 2nd Floor Los Angeles CA CALIFORNIA 90067 Executive Officer Director Dhillon Avtar 1901 Avenue of the Stars, 2nd Floor Los Angeles CA CALIFORNIA 90067 Director Maida Anthony, III 1901 Avenue of the Stars, 2nd Floor Los Angeles CA CALIFORNIA 90067 Director Pharmaceuticals Decline to Disclose 06b false 2018-10-22 false true true true true The Issuer issued 6,000,000 shares of common stock, valued at $1.50 per share, in connection with a business acquisition by the Issuer pursuant to a Share Exchange Agreement (the "Exchange Shares") 0 36000000 36000000 0 Includes (i) 6,000,000 shares of common stock purchased for $1.50 per share and warrants to purchase 6,000,000 shares of common stock for $3.00 per share, and (ii) the Exchange Shares (see item 10). false 32 0 0 0 false Vitality Biopharma, Inc. /s/ Robert Brooke Robert Brooke Chief Executive Officer 2018-11-08